Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Almost 300 million people globally have chronic hepatitis B
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
Subscribe To Our Newsletter & Stay Updated